Breath Test for Head-and-Neck Cancer
Author Information
Author(s): Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, Abdah-Bortnyak R, Kuten A, Haick H
Primary Institution: Technion – Israel Institute of Technology
Hypothesis
Can a breath test using a Nanoscale Artificial Nose (NA-NOSE) effectively diagnose head-and-neck cancer (HNC) and distinguish it from lung cancer (LC) and healthy controls?
Conclusion
The study suggests that a breath test using the NA-NOSE can reliably differentiate between HNC patients, LC patients, and healthy individuals.
Supporting Evidence
- The NA-NOSE could distinguish between HNC patients and healthy controls.
- The NA-NOSE could also differentiate between LC patients and healthy controls.
- Statistically significant differences in breath chemical composition were found among the three groups.
Takeaway
Doctors can use a special breath test to tell if someone has head-and-neck cancer, which could help catch it early.
Methodology
Breath samples were collected from 87 volunteers, including HNC and LC patients and healthy controls, and analyzed using a Nanoscale Artificial Nose and gas chromatography-mass spectrometry.
Potential Biases
Potential confounding factors such as smoking habits were considered, but the study did not fully account for all demographic variations.
Limitations
The study was small-scale and did not distinguish between early-stage and late-stage HNC.
Participant Demographics
Participants included 22 HNC patients, 25 LC patients, and 40 healthy controls, aged 24–78 years.
Statistical Information
P-Value
<0.0001
Confidence Interval
99.9%
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website